Avid Bioservices Inc (CDMO)

[biopharm]

Yes and Ribavirin+Bavituximab...I wonder what the execs would have to say about that Ribapharm breakup now Kim Campbell ..Arnold Kroll ..Hans Thierstein...John Vierling.. Johnson Y.N. Lau as they could easily relate to Peregrine sabotage attempts

"Bavituximab used as a single agent has demonstrated a consistent, acceptable safety profile in three Phase I HCV trials to date, and we have seen enhanced antiviral activity when using bavituximab in combination with the antiviral agent ribavirin in several preclinical viral disease models," said Joseph S. Shan, vice president of clinical and regulatory affairs at Peregrine Pharmaceuticals. "Our recently initiated randomized Phase II trial will assess early virology response of genotype 1 HCV patients after 12 weeks of therapy combining bavituximab with ribavirin as a potential alternative to the current interferon-based regimen."


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126243292